BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36692400)

  • 1. Reliability and Management Outcomes Following a Percutaneous Biopsy Diagnosis of Oncocytoma: A 15-year Retrospective Analysis.
    Chai JL; Alencar RO; Hirsch MS; Bhagavatula S; Bay CP; Siegmund S; Chang SL; Silverman SG
    Radiology; 2023 Apr; 307(2):e221156. PubMed ID: 36692400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An In-vivo Prospective Study of the Diagnostic Yield and Accuracy of Optical Biopsy Compared with Conventional Renal Mass Biopsy for the Diagnosis of Renal Cell Carcinoma: The Interim Analysis.
    Buijs M; Wagstaff PGK; de Bruin DM; Zondervan PJ; Savci-Heijink CD; van Delden OM; van Leeuwen TG; van Moorselaar RJA; de la Rosette JJMCH; Laguna Pes MP
    Eur Urol Focus; 2018 Dec; 4(6):978-985. PubMed ID: 29079496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using Aorta-Lesion-Attenuation Difference on Preoperative Contrast-enhanced Computed Tomography Scan to Differentiate Between Malignant and Benign Renal Tumors.
    Grajo JR; Terry RS; Ruoss J; Noennig BJ; Pavlinec JG; Bozorgmehri S; Crispen PL; Su LM
    Urology; 2019 Mar; 125():123-130. PubMed ID: 30552939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small (< 4 cm) Renal Mass: Differentiation of Oncocytoma From Renal Cell Carcinoma on Biphasic Contrast-Enhanced CT.
    Sasaguri K; Takahashi N; Gomez-Cardona D; Leng S; Schmit GD; Carter RE; Leibovich BC; Kawashima A
    AJR Am J Roentgenol; 2015 Nov; 205(5):999-1007. PubMed ID: 26496547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical histopathology for suspected oncocytoma on renal mass biopsy: a systematic review and meta-analysis.
    Patel HD; Druskin SC; Rowe SP; Pierorazio PM; Gorin MA; Allaf ME
    BJU Int; 2017 May; 119(5):661-666. PubMed ID: 28058773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT.
    Young JR; Margolis D; Sauk S; Pantuck AJ; Sayre J; Raman SS
    Radiology; 2013 May; 267(2):444-53. PubMed ID: 23382290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Performance of Technetium-99m-Sestamibi SPECT/CT Imaging in Differentiating Oncocytic Tumors From Renal Cell Carcinoma in Routine Clinical Practice.
    Schober JP; Braun A; Ginsburg KB; Bell S; Castro Bigalli AA; Chen M; Wang R; Magee D; Bukavina L; Handorf E; Yu JQ; Chen DYT; Greenberg RE; Smaldone MC; Viterbo R; Correa AF; Uzzo RG; Kutikov A
    J Urol; 2023 Sep; 210(3):438-445. PubMed ID: 37378576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active surveillance is suitable for intermediate term follow-up of renal oncocytoma diagnosed by percutaneous core biopsy.
    Liu S; Lee S; Rashid P; Bangash H; Hamid A; Lau J; Cohen R
    BJU Int; 2016 Oct; 118 Suppl 3():30-34. PubMed ID: 27457972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of aorta-lesion-attenuation difference on preoperative contrast-enhanced computed tomography scan to differentiate between malignant and benign oncocytic renal tumors.
    Grajo JR; Batra NV; Bozorgmehri S; Magnelli LL; Pavlinec J; O'Malley P; Su LM; Crispen PL
    Abdom Radiol (NY); 2021 Jul; 46(7):3269-3279. PubMed ID: 33665734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Analysis of Surgery, Thermal Ablation, and Active Surveillance for Renal Oncocytic Neoplasms.
    Miller BL; Mankowski Gettle L; Van Roo JR; Ziemlewicz TJ; Best SL; Wells SA; Lubner MG; Hinshaw JL; Lee FT; Nakada SY; Huang W; Abel EJ
    Urology; 2018 Feb; 112():92-97. PubMed ID: 29030073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aorta-Lesion-Attenuation-Difference (ALAD) on contrast-enhanced CT: a potential imaging biomarker for differentiating malignant from benign oncocytic neoplasms.
    Dhyani M; Grajo JR; Rodriguez D; Chen Z; Feldman A; Tambouret R; Gervais DA; Arellano RS; Hahn PF; Samir AE
    Abdom Radiol (NY); 2017 Jun; 42(6):1734-1743. PubMed ID: 28197683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation of oncocytoma and renal cell carcinoma in small renal masses (<4 cm): the role of 4-phase computerized tomography.
    Bird VG; Kanagarajah P; Morillo G; Caruso DJ; Ayyathurai R; Leveillee R; Jorda M
    World J Urol; 2011 Dec; 29(6):787-92. PubMed ID: 20717829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active Surveillance for Renal Neoplasms with Oncocytic Features is Safe.
    Richard PO; Jewett MA; Bhatt JR; Evans AJ; Timilsina N; Finelli A
    J Urol; 2016 Mar; 195(3):581-6. PubMed ID: 26388501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of multidetector computed tomography to differentiate between renal cell carcinoma and oncocytoma. A model validation.
    Paño B; Soler A; Goldman DA; Salvador R; Buñesch L; Sebastià C; Nicolau C
    Br J Radiol; 2020 Nov; 93(1115):20200064. PubMed ID: 32706993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Segmental enhancement inversion at biphasic multidetector CT: characteristic finding of small renal oncocytoma.
    Kim JI; Cho JY; Moon KC; Lee HJ; Kim SH
    Radiology; 2009 Aug; 252(2):441-8. PubMed ID: 19508984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing oncologic outcomes in patients undergoing surgery for oncocytic neoplasms, conventional oncocytoma, and chromophobe renal cell carcinoma.
    Flack CK; Calaway AC; Miller BL; Picken MM; Gondim DD; Idrees MT; Abel EJ; Gupta GN; Boris RS
    Urol Oncol; 2019 Nov; 37(11):811.e17-811.e21. PubMed ID: 31451335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Voxel-based whole-lesion enhancement parameters: a study of its clinical value in differentiating clear cell renal cell carcinoma from renal oncocytoma.
    Chen F; Gulati M; Hwang D; Cen S; Yap F; Ugwueze C; Varghese B; Desai M; Aron M; Gill I; Duddalwar V
    Abdom Radiol (NY); 2017 Feb; 42(2):552-560. PubMed ID: 27595574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Categorizing renal oncocytic neoplasms on core needle biopsy: a morphologic and immunophenotypic study of 144 cases with clinical follow-up.
    Alderman MA; Daignault S; Wolf JS; Palapattu GS; Weizer AZ; Hafez KS; Kunju LP; Wu AJ
    Hum Pathol; 2016 Sep; 55():1-10. PubMed ID: 27085554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small renal oncocytomas: is segmental enhancement inversion a characteristic finding at biphasic MDCT?
    O'Malley ME; Tran P; Hanbidge A; Rogalla P
    AJR Am J Roentgenol; 2012 Dec; 199(6):1312-5. PubMed ID: 23169723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bilateral benign renal oncocytomas and the role of renal biopsy: single institution review.
    Leone AR; Kidd LC; Diorio GJ; Zargar-Shoshtari K; Sharma P; Sexton WJ; Spiess PE
    BMC Urol; 2017 Jan; 17(1):6. PubMed ID: 28081704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.